Home > Healthcare > Medical Devices > Medical Supplies > organ preservation solution market
Get a free sample of Organ Preservation Solution Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Organ Preservation Solution Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
University of Wisconsin (UW) segment accounted for 38.2% share of the organ preservation solution industry in 2022 and is estimated to record substantial growth through 2032 attributed to the presence of established distribution networks for facilitating its accessibility to transplantation centers.
Organ preservation solution industry size reached USD 256.1 million in 2022 and is projected to expand at 6.8% CAGR from 2023-2032 driven by the rising number of organ transplantation procedures coupled with the massive healthcare investments.
Some major organ preservation solution firms are Waters Medical Systems LLC, Xvivo Perfusion AB, Transmedics, Inc., Preservation Solutions, Inc., Paragonix Technologies, Inc., Organox Limited, Dr. Franz Koehler Chemie GmbH, Accord Healthcare Inc., and Shanghai Genext Medical Technology.
North America organ preservation solution market was worth USD 103 million in revenue in 2022 and is anticipated to reach USD 196.5 million by 2032 driven by the well-developed and advanced healthcare infrastructure.